Lactulose and Haptoglobin decreased - a phase IV clinical study of FDA data
Summary:
Haptoglobin decreased is reported as a side effect among people who take Lactulose (lactulose), especially for people who are female, 40-49 old, also take Lasix, and have Oedema peripheral.
The phase IV clinical study analyzes which people have Haptoglobin decreased when taking Lactulose. It is created by eHealthMe based on reports of 46,694 people who have side effects when taking Lactulose from the FDA, and is updated regularly.
What is Lactulose?
Lactulose has active ingredients of lactulose. It is often used in constipation. eHealthMe is studying from 46,960 Lactulose users. Check the latest studies of Lactulose.
What is Haptoglobin decreased?
Haptoglobin decreased is found to be associated with 130 drugs and 277 conditions by eHealthMe. Check the latest studies of Haptoglobin decreased.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
46,694 people reported to have side effects when taking Lactulose.
Among them, 14 people (0.03%) have Haptoglobin decreased.

Among these 14 people:
What is the gender of people who have Haptoglobin decreased when taking Lactulose? *
- female: 71.43 %
- male: 28.57 %
What is the age of people who have Haptoglobin decreased when taking Lactulose? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 7.14 %
- 20-29: 0.0 %
- 30-39: 7.14 %
- 40-49: 35.71 %
- 50-59: 21.43 %
- 60+: 28.57 %
What are other drugs people take besides Lactulose? *
- Lasix: 6 people, 42.86%
- Revatio: 4 people, 28.57%
- Xifaxan: 4 people, 28.57%
- Xarelto: 4 people, 28.57%
- Actigall: 4 people, 28.57%
- Opsumit: 4 people, 28.57%
- Aldactone: 4 people, 28.57%
- Cephulac: 4 people, 28.57%
- Oxycodone: 4 people, 28.57%
- Zantac: 4 people, 28.57%
What are other side effects people have besides Haptoglobin decreased? *
- Blood Lactate Dehydrogenase Increased: 12 people, 85.71%
- Blood Bilirubin Increased: 10 people, 71.43%
- Haemoglobin Decreased: 9 people, 64.29%
- Back Pain: 7 people, 50.00%
- Chills (felling of cold): 6 people, 42.86%
- Oedema Peripheral (superficial swelling): 6 people, 42.86%
- Acute Kidney Failure: 6 people, 42.86%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 6 people, 42.86%
- Haematocrit Decreased: 5 people, 35.71%
- Encephalopathy (functioning of the brain is affected by some agent or condition): 5 people, 35.71%
What are the existing conditions these people have? *
- Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 4 people, 28.57%
- Oedema Peripheral (superficial swelling): 4 people, 28.57%
- Idiopathic Thrombocytopenic Purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 2 people, 14.29%
- Essential Hypertension (primary hypertension): 2 people, 14.29%
- Thrombosis (formation of a blood clot inside a blood vessel): 1 person, 7.14%
- Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs): 1 person, 7.14%
- Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 1 person, 7.14%
- Hepatic Failure (liver failure): 1 person, 7.14%
- Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 1 person, 7.14%
- Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 7.14%
* Approximation only. Some reports may have incomplete information.
Do you take Lactulose and have Haptoglobin decreased?
- Check whether Haptoglobin decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Lactulose:
- Lactulose (46,960 reports)
Haptoglobin decreased treatments and more:
- Haptoglobin decreased (1,203 reports)
How severe was Haptoglobin decreased and when was it recovered:
Expand to all the drugs that have ingredients of lactulose:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Lactulose:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Haptoglobin decreased:
- Haptoglobin decreased (130 drugs)
Browse all the conditions that are associated with Haptoglobin decreased:
- Haptoglobin decreased (277 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on lactulose (the active ingredients of Lactulose) and Lactulose (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Ultram cause Retinal Ischaemia? - 7 seconds ago
- Could Lovastatin cause Diplopia? - 15 seconds ago
- Could Prolia cause Guillain-Barre Syndrome? - 19 seconds ago
- Could Prolia cause Guillain-Barré Syndrome? - 19 seconds ago
- White Blood Cell Count Decreased and Hoarseness Or Changing Voice - 20 seconds ago
- Could Prolia cause Guillain Barre Syndrome? - 20 seconds ago
- Could Coumadin cause Orthostatic Hypotension? - 22 seconds ago
- Sumatriptan Succinate vs. Rizatriptan Benzoate, side effect and effectiveness comparison - 38 seconds ago
- Could Prednisone cause Blood Urea Nitrogen/Creatinine Ratio Increased? - 40 seconds ago
- Could Taxol cause Osteoporosis? - 40 seconds ago